background image

Paid Clinical Trials Iowa

Discover 707 paid clinical trials in Iowa. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Pegozafermin

Recruiting
PHASE3

Sponsor:

89bio, Inc.

Location:

Iowa City IA, Rochester MN, Minneapolis MN, Topeka KSshow 89 more

Code:

NCT06419374

Conditions

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Pegozafermin

Placebo

KC002

Recruiting
PHASE2

Sponsor:

KeraCure

Location:

Clinton IA, Livonia MI, Erie PA, Warren PAshow 17 more

Code:

NCT00330265

Conditions

Foot Ulcer

Diabetes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

KC-002

Conventional Wound Therapy

Thoracotomy vs. Thoracoscopic

Recruiting
PHASE3

Sponsor:

Children's Oncology Group

Location:

Des Moines IA, Iowa City IA, Rochester MN, Omaha NEshow 144 more

Code:

NCT05235165

Conditions

Metastatic Malignant Neoplasm in the Lung

Metastatic Osteosarcoma

Osteosarcoma

Eligibility Criteria

Sex: All

Age: 0 - 50

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Computed Tomography

Questionnaire Administration

Thoracoscopy

Thoracotomy

IMC-F106C & Checkpoint Inhibitors

Recruiting
PHASE1
PHASE2

Sponsor:

Immunocore Ltd

Location:

Iowa City IA, Madison WI, Chicago IL, Oklahoma City OKshow 18 more

Code:

NCT04262466

Conditions

Select Advanced Solid Tumors

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Brenetafusp

Brenetafusp and pembrolizumab

Brenetafusp and chemotherapy

Brenetafusp and monoclonal antibodies and chemotherapy

Brenetafusp and tebentafusp

Combination Chemotherapy

Recruiting
PHASE3

Sponsor:

University of Leicester

Location:

Iowa City IA, Rochester MN, St. Paul MN, Minneapolis MNshow 88 more

Code:

NCT00020566

Conditions

Sarcoma

Eligibility Criteria

Sex: All

Age: 0 - 49

Healthy Volunteers: Not accepted

Interventions

dactinomycin

busulfan

doxorubicin hydrochloride

etoposide

ifosfamide

Camizestrant

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Des Moines IA, Rochester MN, Omaha NE, Lincoln NEshow 143 more

Code:

NCT05952557

Conditions

Breast Cancer, Early Breast Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Camizestrant

Tamoxifen

Anastrozole

Letrozole

Exemestane

Selumetinib vs. Carboplatin/Vincristine

Recruiting
PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Des Moines IA, Iowa City IA, Rochester MN, Omaha NEshow 104 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

BMS-986278

Recruiting
PHASE3

Sponsor:

Bristol-Myers Squibb

Location:

Iowa City IA, Peoria IL, Kansas City KS, Chesterfield MOshow 87 more

Code:

NCT06003426

Conditions

Idiopathic Pulmonary Fibrosis

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

BMS-986278

BMS-986278 Placebo

INBRX-106 & Pembrolizumab

Recruiting
PHASE1
PHASE2

Sponsor:

Inhibrx Biosciences, Inc

Location:

Iowa City IA, Omaha NE, Milwaukee WI, Chicago ILshow 12 more

Code:

NCT04198766

Conditions

Solid Tumor

Non-Small Cell Lung Cancer

Head and Neck Cancer

Melanoma

Gastric Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

INBRX-106 - Hexavalent OX40 agonist antibody

pembrolizumab 200 mg

pembrolizumab 400 mg

Carboplatin AUC-5

Carboplatin AUC-6

Observational Study

Recruiting

Sponsor:

Novartis Pharmaceuticals

Location:

Iowa City IA, Minneapolis MN, Madison WI, Kansas City KSshow 44 more

Code:

NCT04174157

Conditions

Spinal Muscular Atrophy (SMA)

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Prospective observational registry

Zolgensma

Popular cities in Iowa

Offering a distinguished healthcare infrastructure and top class research institutions, Iowa has emerged as a significant base for a wide range of clinical trials. Major institutions such as the University of Iowa Hospitals and Clinics and the Holden Comprehensive Cancer Center are at the forefront of these studies, driving advancements in fields like oncology, cardiovascular research, and more. Iowa’s commitment to medical innovation and its growing network of research centers make it a developing hub in cutting-edge clinical trials.

Why choose Iowa for clinical trials?

Common conditions studied in Iowa

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Iowa